Analysis of metatranscriptomic methods to enable wastewater-based biosurveillance of all infectious diseases.

biosurveillance genomics infectious disease metatranscriptomics sequencing wastewater-based epidemiology

Journal

Frontiers in public health
ISSN: 2296-2565
Titre abrégé: Front Public Health
Pays: Switzerland
ID NLM: 101616579

Informations de publication

Date de publication:
2023
Historique:
received: 17 01 2023
accepted: 27 02 2023
medline: 11 4 2023
entrez: 10 4 2023
pubmed: 11 4 2023
Statut: epublish

Résumé

Wastewater-based surveillance emerged during the COVID-19 pandemic as an efficient way to quickly screen large populations, monitor infectious disease transmission over time, and identify whether more virulent strains are becoming more prevalent in the region without burdening the health care system with individualized testing. Ohio was one of the first states to implement wastewater monitoring through its Ohio Coronavirus Wastewater Monitoring Network (OCWMN), originally tracking the prevalence of COVID-19 by quantitative qPCR from over 67 sites across the state. The OCWMN evolved along with the pandemic to include sequencing the SARS-CoV-2 genome to assess variants of concern circulating within the population. As the pandemic wanes, networks such as OCWMN can be expanded to monitor other infectious diseases and outbreaks of interest to the health department to reduce the burden of communicable diseases. However, most surveillance still utilizes qPCR based diagnostic tests for individual pathogens, which is hard to scale for surveillance of multiple pathogens. Here we have tested several genomic methods, both targeted and untargeted, for wastewater-based biosurveillance to find the most efficient procedure to detect and track trends in reportable infectious diseases and outbreaks of known pathogens as well as potentially novel pathogens or variants on the rise in our communities. RNA extracts from the OCWMN were provided weekly from 10 sites for 6 weeks. Total RNA was sequenced from the samples on the Illumina NextSeq and on the MinION to identify pathogens present. The MinION long read platform was also used to sequence SARS-CoV-2 with the goal of reducing the complexity of variant calling in mixed populations as occurs with short Illumina reads. Finally, a targeted hybridization approach was tested for compatibility with wastewater RNA samples. The data analyzed here provides a baseline assessment that demonstrates that wastewater is a rich resource for infectious disease epidemiology and identifies technology gaps and potential solutions to enable this resource to be used by public health laboratories to monitor the infectious disease landscape of the regions they serve.

Identifiants

pubmed: 37033057
doi: 10.3389/fpubh.2023.1145275
pmc: PMC10073511
doi:

Substances chimiques

Wastewater 0
RNA 63231-63-0

Types de publication

Journal Article Research Support, U.S. Gov't, P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

1145275

Informations de copyright

Copyright © 2023 Spurbeck, Catlin, Mukherjee, Smith and Minard-Smith.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Genome Res. 2004 Nov;14(11):2295-307
pubmed: 15520292
Sci Total Environ. 2021 Oct 1;789:147829
pubmed: 34051492
Sci Total Environ. 2022 Feb 25;809:152190
pubmed: 34890655
Environ Health. 2005 Aug 05;4:14
pubmed: 16083497
Sci Total Environ. 2020 Oct 15;739:139076
pubmed: 32758929
mSystems. 2018 May 22;3(3):
pubmed: 29795788
Sci Rep. 2019 Jul 4;9(1):9673
pubmed: 31273307
Antibiotics (Basel). 2021 Jul 15;10(7):
pubmed: 34356780
Sci Total Environ. 2020 Oct 1;737:140405
pubmed: 32783878
Curr Opin Environ Sci Health. 2020 Oct;17:1-7
pubmed: 32395676
Sci Total Environ. 2022 Aug 20;835:155347
pubmed: 35460780
Parasitol Res. 2021 Dec;120(12):4167-4188
pubmed: 33409629
mSphere. 2020 May 13;5(3):
pubmed: 32404515
PLoS One. 2020 Sep 3;15(9):e0238438
pubmed: 32881972
Int J Epidemiol. 2003 Oct;32(5):772-7
pubmed: 14559748
mBio. 2022 Aug 30;13(4):e0059122
pubmed: 35726918
Bioinformatics. 2014 Aug 1;30(15):2114-20
pubmed: 24695404
Curr Protoc Bioinformatics. 2020 Jun;70(1):e102
pubmed: 32559359
Funct Integr Genomics. 2019 Nov;19(6):839-851
pubmed: 31111267
Environ Sci Pollut Res Int. 2022 Apr;29(16):22829-22842
pubmed: 35048346
Appl Environ Microbiol. 2019 May 2;85(10):
pubmed: 30902850
Environ Sci Technol. 2006 Dec 1;40(23):7141-9
pubmed: 17180960
mBio. 2021 Jan 19;12(1):
pubmed: 33468686
Nat Methods. 2021 Apr;18(4):366-368
pubmed: 33828273
Water Res. 2022 Sep 1;223:118904
pubmed: 36007397
Sci Rep. 2022 Sep 22;12(1):15777
pubmed: 36138059
Int Sch Res Notices. 2014 Oct 02;2014:109583
pubmed: 27350960
Sci Total Environ. 2020 Aug 1;728:138764
pubmed: 32387778
Appl Environ Microbiol. 2017 Apr 17;83(9):
pubmed: 28213546
Microbiol Spectr. 2021 Oct 31;9(2):e0094121
pubmed: 34468194
Viruses. 2022 May 09;14(5):
pubmed: 35632752
Nat Biotechnol. 2013 Jun;31(6):533-8
pubmed: 23707974
Genome Biol. 2019 Nov 28;20(1):257
pubmed: 31779668
Nature. 2022 Sep;609(7925):101-108
pubmed: 35798029

Auteurs

Rachel R Spurbeck (RR)

Health Business Unit, Drug Development and Precision Diagnostics Division, Life Sciences Research Business Line, Battelle Memorial Institute, Columbus, OH, United States.

Lindsay A Catlin (LA)

National Security Business Unit, Bioscience Center, CBRNE Business Line, Battelle Memorial Institute, Columbus, OH, United States.

Chiranjit Mukherjee (C)

Health Business Unit, Health Analytics Division, Health Outcomes and Biotechnology Solutions Business Line, Battelle Memorial Institute, Columbus, OH, United States.

Anthony K Smith (AK)

National Security Business Unit, Bioscience Center, CBRNE Business Line, Battelle Memorial Institute, Columbus, OH, United States.

Angela Minard-Smith (A)

Health Business Unit, Health Analytics Division, Health Outcomes and Biotechnology Solutions Business Line, Battelle Memorial Institute, Columbus, OH, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH